Stockreport

Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF immune disease treatment ?from Chinese biotech firm TJ Biopharma, giving the U.S. drugmaker worldwide rights to develop ?and market the treatment. • Shares of Biogen w [Read more]